Letroz (letrozole) 2.5mg Tablets 25’s

Indications of letroz:

• Treatment of hormone receptor-positive breast cancer in postmenopausal women
• Adjuvant therapy (after surgery) to reduce cancer recurrence
• Extended adjuvant treatment after completion of 5 years of tamoxifen therapy
• First-line treatment of advanced or metastatic breast cancer
• May be prescribed for other estrogen-related conditions as directed by a doctor

How to use letrozole:

• Oral use only
• Usual dose: 1 tablet (2.5mg) once daily, at the same time each day or as directed by a oncologist
• Can be taken with or without food
• Treatment duration is determined by the oncologist and may last for several years in adjuvant therapy

Safety Information:

• Not suitable for use in premenopausal women, pregnancy, or breastfeeding
• Common side effects: hot flushes, fatigue, sweating, joint or muscle pain, headache, nausea
• May cause bone thinning (osteoporosis) – bone density monitoring may be recommended
• Rare but serious risks: blood clots, liver dysfunction, or severe allergic reactions
• Inform your doctor about all medications you are taking to avoid interactions
• Effective contraception should be used if there is a chance of pregnancy

Notice:
Letroz (Letrozole) 2.5mg is a prescription-only medicine. Use only under the supervision of an oncologist or qualified healthcare professional.